These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 20232091)

  • 1. Peptide heterodimers for molecular imaging.
    Yan Y; Chen X
    Amino Acids; 2011 Nov; 41(5):1081-92. PubMed ID: 20232091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and applications of bispecific heterodimers: molecular imaging and beyond.
    Luo H; Hong H; Yang SP; Cai W
    Mol Pharm; 2014 Jun; 11(6):1750-61. PubMed ID: 24738564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein-based tumor molecular imaging probes.
    Lin X; Xie J; Chen X
    Amino Acids; 2011 Nov; 41(5):1013-36. PubMed ID: 20232092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new 18F-labeled BBN-RGD peptide heterodimer with a symmetric linker for prostate cancer imaging.
    Yan Y; Chen K; Yang M; Sun X; Liu S; Chen X
    Amino Acids; 2011 Jul; 41(2):439-47. PubMed ID: 20936525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual-targeted molecular probes for cancer imaging.
    Liu Z; Wang F
    Curr Pharm Biotechnol; 2010 Sep; 11(6):610-9. PubMed ID: 20497116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective formation of ErbB-2/ErbB-3 heterodimers depends on the ErbB-3 affinity of epidermal growth factor-like ligands.
    Stortelers C; van der Woning SP; Jacobs-Oomen S; Wingens M; van Zoelen EJ
    J Biol Chem; 2003 Apr; 278(14):12055-63. PubMed ID: 12556529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro characterization of a bivalent anti-HER-2 affibody with potential for radionuclide-based diagnostics.
    Steffen AC; Wikman M; Tolmachev V; Adams GP; Nilsson FY; Ståhl S; Carlsson J
    Cancer Biother Radiopharm; 2005 Jun; 20(3):239-48. PubMed ID: 15989469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bivalent ligands as probes of estrogen receptor action.
    Bergmann KE; Wooge CH; Carlson KE; Katzenellenbogen BS; Katzenellenbogen JA
    J Steroid Biochem Mol Biol; 1994 Jun; 49(2-3):139-52. PubMed ID: 8031710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optical and multimodal peptide-based probes for in vivo molecular imaging.
    Melendez-Alafort L; Muzzio PC; Rosato A
    Anticancer Agents Med Chem; 2012 Jun; 12(5):476-99. PubMed ID: 22292759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative evaluation of dimeric and monomeric forms of ADAPT scaffold protein for targeting of HER2-expressing tumours.
    Garousi J; Lindbo S; Borin J; von Witting E; Vorobyeva A; Oroujeni M; Mitran B; Orlova A; Buijs J; Tolmachev V; Hober S
    Eur J Pharm Biopharm; 2019 Jan; 134():37-48. PubMed ID: 30408518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiometal targeted tumor diagnosis and therapy with peptide hormones.
    Zwanziger D; Beck-Sickinger AG
    Curr Pharm Des; 2008; 14(24):2385-400. PubMed ID: 18781989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PESIN multimerization improves receptor avidities and in vivo tumor targeting properties to GRPR-overexpressing tumors.
    Lindner S; Michler C; Wängler B; Bartenstein P; Fischer G; Schirrmacher R; Wängler C
    Bioconjug Chem; 2014 Mar; 25(3):489-500. PubMed ID: 24533789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptide-based imaging agents for cancer detection.
    Sun X; Li Y; Liu T; Li Z; Zhang X; Chen X
    Adv Drug Deliv Rev; 2017 Feb; 110-111():38-51. PubMed ID: 27327937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein scaffold-based molecular probes for cancer molecular imaging.
    Miao Z; Levi J; Cheng Z
    Amino Acids; 2011 Nov; 41(5):1037-47. PubMed ID: 20174842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis and in vitro evaluation of heterobivalent peptidic radioligands targeting both GRP- and VPAC
    Lindner S; Fiedler L; Wängler B; Bartenstein P; Schirrmacher R; Wängler C
    Eur J Med Chem; 2018 Jul; 155():84-95. PubMed ID: 29864700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A flexible method for preparation of peptide homo- and heterodimers functionalized with affinity probes, chelating ligands, and latent conjugating groups.
    Pillai R; Marinelli ER; Swenson RE
    Biopolymers; 2006; 84(6):576-85. PubMed ID: 16845666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Avidity-mediated enhancement of in vivo tumor targeting by single-chain Fv dimers.
    Adams GP; Tai MS; McCartney JE; Marks JD; Stafford WF; Houston LL; Huston JS; Weiner LM
    Clin Cancer Res; 2006 Mar; 12(5):1599-605. PubMed ID: 16533787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different epidermal growth factor (EGF) receptor ligands show distinct kinetics and biased or partial agonism for homodimer and heterodimer formation.
    Macdonald-Obermann JL; Pike LJ
    J Biol Chem; 2014 Sep; 289(38):26178-26188. PubMed ID: 25086039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Two Optical Probes for Imaging the Integrin α
    Ganguly T; Tang SY; Bauer N; Sutcliffe JL
    Mol Imaging Biol; 2020 Oct; 22(5):1170-1181. PubMed ID: 32002763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controlled dimerization of ErbB receptors provides evidence for differential signaling by homo- and heterodimers.
    Muthuswamy SK; Gilman M; Brugge JS
    Mol Cell Biol; 1999 Oct; 19(10):6845-57. PubMed ID: 10490623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.